EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 13-May-2025 08:09 ET (13-May-2025 12:09 GMT/UTC)

The Wistar Institute scientists discover new weapon to fight treatment-resistant melanoma

The Wistar Institute
Peer-Reviewed Publication

Wistar Institute scientists identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2.

Journal: Science Translational Medicine
Funder: NIH/National Institutes of Health, U.S. Department of Defense, Pennsylvania Department of Health, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Melanoma Research Alliance, V Foundation for Cancer Research, Wistar Science Accelerator Award, The Goldblum Family Healthcare Fund

"Infant formula marketing in Ecuador: a threat to breastfeeding"

Escuela Superior Politecnica del Litoral
Peer-Reviewed Publication

The marketing of breast milk substitutes (BMS) significantly influences infant feeding practices worldwide. In Ecuador, despite regulatory efforts aligned with the WHO’s International Code of Marketing of Breast Milk Substitutes, industry advertising strategies continue to impact the decisions of both mothers and healthcare professionals. This cross-sectional study assessed compliance with the Code in Ecuador through surveys of mothers (n=330) and healthcare professionals (n=66), observations in healthcare facilities (n=33) and retail outlets (n=44), as well as media monitoring and product labeling evaluations.

Journal: Maternal and Child Nutrition
Funder: UNICEF

RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment

Vall d'Hebron Institute of Oncology
Peer-Reviewed Publication

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and treatment selection in metastatic prostate cancer (mPC).

Journal: Cell Reports Medicine

Cancer vaccine shows promise for patients with stage III and IV kidney cancer

Dana-Farber Cancer Institute
Peer-Reviewed Publication

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

Journal: Nature

ACC to host Cardio-oncology Conference in Washington and virtually

American College of Cardiology
Meeting Announcement

Taking place on February 14-16, 2025, in Washington, the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient conference is an interdisciplinary and inter-specialty conference designed to provide clinicians with the tools needed to improve the cardiovascular care of cancer patients in everyday practice.

Meeting: ACC Advancing the Cardiovascular Care of the Oncology Patient

New data sets from NIH Kids First Program accelerates rare childhood disease research

Gabriella Miller Kids First Data Resource Center
Business Announcement

The new Kids First datasets advance our understanding of how genetics contribute to childhood cancers and congenital disorders, opening new doors for prevention and treatment.

Cervical cancer: Maternal, delivery & neonatal outcomes study

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY—February 5, 2025— A new research paper was published in Oncoscience’s Volume 12 on January 20, 2025, titled “Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database."

Journal: Oncoscience

Children’s National Hospital, Virginia Tech expand research partnership to advance pediatric health

Virginia Tech
Business Announcement

Children’s National Hospital and Virginia Tech are expanding their research partnership, building on a successful collaboration established through the FBRI, beginning in 2019. This partnership will advance pediatric health through innovative discoveries and therapies with an initial focus on pediatric cancers, including brain tumors. Together, Children’s National, ranked among the nation’s top pediatric hospitals by U.S. News & World Report, and Virginia Tech, a nationally leading academic research university, aim to deliver transformative advancements to enhance outcomes for children facing devastating cancer diagnoses.

Outside-in signaling shows a route into cancer cells

University of California - Davis
Peer-Reviewed Publication

Anew study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism that could be exploited for delivering other drugs.

Journal: Nature Communications
Funder: NIH/National Institute of General Medical Sciences

Pickleball program boosts health and wellness for cancer survivors, Moffitt study finds

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

A new community-based pickleball program called Project Rally is helping cancer survivors improve their physical and social well-being, according to a recent pilot study led by researchers at Moffitt Cancer Center. The program, which is offered in partnership with the YMCA of the Suncoast, has shown strong results in terms of participation, enjoyment, and physical improvements.

Journal: Healthcare